Leap Therapeutics (LPTX) Competitors

Leap Therapeutics (NASDAQ:LPTX) and PyroGenesis Canada (NASDAQ:PYRGF) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

Is LPTX or PYRGF more profitable?

Leap Therapeutics has a net margin of 0.00% compared to PyroGenesis Canada's net margin of -115.14%. PyroGenesis Canada's return on equity of 0.00% beat Leap Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Leap Therapeutics	N/A	-116.24%	-93.18%
PyroGenesis Canada	-115.14%	N/A	-60.81%

Which has stronger valuation & earnings, LPTX or PYRGF?

PyroGenesis Canada has higher revenue and earnings than Leap Therapeutics. PyroGenesis Canada is trading at a lower price-to-earnings ratio than Leap Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Leap Therapeutics	N/A	N/A	-$81.41M	-$1.70	-0.22
PyroGenesis Canada	$9.14M	6.66	-$21.12M	-$0.02	-16.30

Does the MarketBeat Community prefer LPTX or PYRGF?

Leap Therapeutics received 294 more outperform votes than PyroGenesis Canada when rated by MarketBeat users.

Company	Underperform	Outperform
Leap Therapeutics	Outperform Votes 294 68.37%	Underperform Votes 136 31.63%
PyroGenesis Canada	N/A	N/A

Does the media refer more to LPTX or PYRGF?

In the previous week, Leap Therapeutics had 5 more articles in the media than PyroGenesis Canada. MarketBeat recorded 7 mentions for Leap Therapeutics and 2 mentions for PyroGenesis Canada. Leap Therapeutics' average media sentiment score of 0.77 beat PyroGenesis Canada's score of 0.23 indicating that Leap Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Leap Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PyroGenesis Canada	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has more volatility & risk, LPTX or PYRGF?

Leap Therapeutics has a beta of -0.17, indicating that its share price is 117% less volatile than the S&P 500. Comparatively, PyroGenesis Canada has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500.

Do institutionals and insiders believe in LPTX or PYRGF?

30.5% of Leap Therapeutics shares are held by institutional investors. Comparatively, 0.0% of PyroGenesis Canada shares are held by institutional investors. 5.4% of Leap Therapeutics shares are held by insiders. Comparatively, 47.7% of PyroGenesis Canada shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Do analysts recommend LPTX or PYRGF?

Leap Therapeutics currently has a consensus price target of $4.92, indicating a potential upside of 1,193.86%. Given Leap Therapeutics' stronger consensus rating and higher probable upside, equities analysts clearly believe Leap Therapeutics is more favorable than PyroGenesis Canada.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Leap Therapeutics	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
PyroGenesis Canada	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Leap Therapeutics beats PyroGenesis Canada on 9 of the 16 factors compared between the two stocks.